The symposium is co-organized by the Association for Cancer Immunotherapy (CIMT) and the Cancer Immunotherapy Consortium (CIC) of the Cancer Research Institute and will feature perspectives on actively personalized cancer vaccines and combination therapies, including clinical development and regulatory perspectives. Experts from the US, Canada and Europe will present at the symposium, including Robert Holt (BCCA Genome Sciences Centre), Laurence Zitvogel (Institut Gustave Roussy) and James Allison (Memorial Sloan-Kettering Cancer Center).
For the detailed program, click here.
FOCIS is the leading collaborative forum for education, research and networking across the broad field of clinical immunology. Since its conception in 2001, the FOCIS organization has grown to 52 Member Societies that collectively represent over 65,000 basic and clinician scientists. Each year, the FOCIS meeting brings together these researchers and clinicians from around the world, working in more than 30 clinical specialties and provides them with a forum to gather and share the latest findings, breakthroughs and therapies related to human disease. The FOCIS concept posits that interrelationships between fields sharing clinical immunology expertise will build a better and faster pathway to improve knowledge that leads to new therapies for inflammatory and immunologic diseases.